Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US | Adolescent Medicine | JAMA Network Open | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
1.
Burger  EA, Smith  MA, Killen  J,  et al.  Projected time to elimination of cervical cancer in the USA: a comparative modelling study.   Lancet Public Health. 2020;5(4):e213-e222. doi:10.1016/S2468-2667(20)30006-2 PubMedGoogle ScholarCrossref
2.
Boersma  P, Black  LI.  Human papillomavirus vaccination among adults aged 18-26, 2013-2018.   NCHS Data Brief. 2020;(354):1-8.PubMedGoogle Scholar
3.
Sabatino  SA, Thompson  TD, White  MC,  et al.  Cancer screening test receipt—United States, 2018.   MMWR Morb Mortal Wkly Rep. 2021;70(2):29-35. doi:10.15585/mmwr.mm7002a1 PubMedGoogle ScholarCrossref
4.
Curry  SJ, Krist  AH, Owens  DK,  et al; US Preventive Services Task Force.  Screening for cervical cancer: US Preventive Services Task Force recommendation statement.   JAMA. 2018;320(7):674-686. doi:10.1001/jama.2018.10897 PubMedGoogle ScholarCrossref
5.
Deshmukh  AA, Suk  R, Shiels  MS,  et al.  Incidence trends and burden of human papillomavirus–associated cancers among women in the United States, 2001-2017.   J Natl Cancer Inst. 2021;113(6):792-796. doi:10.1093/jnci/djaa128 PubMedGoogle ScholarCrossref
6.
Miller  MJ, Xu  L, Qin  J,  et al.  Impact of COVID-19 on cervical cancer screening rates among women aged 21-65 years in a large integrated health care system—Southern California, January 1-September 30, 2019, and January 1-September 30, 2020.   MMWR Morb Mortal Wkly Rep. 2021;70(4):109-113. doi:10.15585/mmwr.mm7004a1 PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Views 2,073
    Citations 0
    Research Letter
    Public Health
    October 26, 2021

    Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US

    Author Affiliations
    • 1Center for Health Services Research, Department of Management, Policy & Community Health, UTHealth School of Public Health, Houston, Texas
    • 2Center for Healthcare Data, Department of Management, Policy & Community Health, UTHealth School of Public Health, Houston, Texas
    • 3Department of Epidemiology, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, Texas
    • 4Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, Texas
    • 5Department of Pediatrics, Baylor College of Medicine, Houston, Texas
    • 6Center for Health Promotion and Prevention Research, UTHealth School of Public Health, Houston, Texas
    JAMA Netw Open. 2021;4(10):e2131129. doi:10.1001/jamanetworkopen.2021.31129
    ×